Senior Director, Clinical Pharmacology Lead
Intellia Therapeutics, New Jersey, United States
Penny is in the position of Senior Director Clinical Pharmacology at Intellia Therapeutics, heading the clinical pharmacology line function activites. Penny has worked in the Phama industry for 18 years and she has worked as both Clinical Pharmacolgist as well as Pharmacometrician and supported multiple successful submissions and approvals of BLAs and sNDA. The approved drugs Penny worked on include Rixathon, Darzalex, Rivaroxaban, Ravulizumab, Danicopan. Penny has published in >30 scientific journal articles/book chapters.
Disclosure information not submitted.
Applications and Challenges of MIDD in Nucleic Acid therapies
Sunday, October 19, 2025
11:00 AM - 12:30 PM MDT
Clinical Pharmacology and Translational Considerations in the Development of CRISPR-Based Therapies
Sunday, October 19, 2025
11:40 AM - 12:00 PM MDT
Panel - Applications and Challenges of MIDD in Nucleic Acid therapies
Sunday, October 19, 2025
12:00 PM - 12:30 PM MDT